05 Oct U.S. FDA Doubles Patient Numbers Permitted for Compassionate Use of ReCell®
The U.S. Food and Drug Administration (FDA) for the expansion of its Compassionate Use Investigational Device Exemption (IDE) program for ReCell®. Read More
The U.S. Food and Drug Administration (FDA) for the expansion of its Compassionate Use Investigational Device Exemption (IDE) program for ReCell®. Read More
Sorry, the comment form is closed at this time.